Prevalence of antiphospholipid antibodies and lupus anticoagulant in juvenile patients with objectively documented deep-vein thrombosis

Clinical and Applied Thrombosis/Hemostasis

Volumn 2, Issue 1, 1996, Pages 69-73

  Zanon, E ^a,b   Saracino, M A ^a   Simioni, Paolo ^a   Cogo, Alberto ^a   Fadin, M A ^a   Gavasso, S ^a   Girolami, Antonio ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b Institute of Medical Semeiotics   (Italy)

Author keywords

Antiphospholipid antibodies; Deep vein thrombosis; Lupus anticoagulant

Indexed keywords

EID: 0002164121     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602969600200114     Document Type: Article

References (35)

1. Feinstein DI, Rapaport SI. Acquired inhibitors of blood coagulation. Prog Hemost Thromb 1972;1:75.
2. Loizou S, McCrea JD, Rudge AC, et al. Measurement of anticardiolipin antibodies by an enzyme linked immunosorbent assay (ELISA): standardization and quantitation of results. Clin Exp Immunol 1986;62:738.
3. Shi W, Krilis SA, Chon BH, et al. Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population. Aust NZ J Med 1990;20:231.
4. Bowie EJW, Thompson JM, Pascuzzi PA, et al. Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. J Lab Clin Med 1963;162:417.
5. Boey ML, Colaco CB, Gharavi AE, et al. Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant. Br Med J 1983; 287:1021.
6. Elias M, Eldor A. Thromboembolism in patients with the lupus type circulating anticoagulant. Arch Intern Med 1984; 144:510.
7. Glueck HI, Kant KS, Weiss MA, et al. Thrombosis in systemic lupus erythematosus. Arch Intern Med 1985;145:1389.
8. Kornberg A, Silber L, Yona R, et al. Clinical manifestations and laboratory findings in patients with lupus anticoagulants. Eur J Haematol 1989;42:90.
9. Feinstein DI. Lupus anticoagulant, anticardiolipin antibodies, fetal loss, and systemic lupus erythematosus. Blood 1992;80:859.
10. Ryan P, Street A. Thrombosis and antiphospholipid antibodies - an evolving story. Aust NZ J Med 1993;23:148-50.
11. Bick RL, Baker WF. Anticardiolipin antibodies and thrombosis Hematol Oncol Clin North Am 1992;6:1287.
12. Manoharan A, Gibson L, Ruch B, et al. Recurrent venous thrombosis with a "lupus" coagulation inhibitor in the absence of systemic lupus. Aust NZ J Med 1977;7:422.
13. Asherson RA. A primary antiphospholipid syndrome. J Rheumatol 1988;15:1742.
14. Lechner K, Pabinger-Fasching I. Lupus anticoagulant and thrombosis. A study of 25 cases and review of the literature. Haemostasis 1985;15:254.
15. Kapiotis S, Speiser W, Pabinger-Fasching I, et al. Anticardiolipin antibodies in patients with venous thrombosis. Haemostasis 1991;21:19.
16. Palareti G, Legnani C, Ludovici S, et al. Prevalence of high levels of antiphospholipid antibodies in otherwise unexplained juvenile venous thromboembolism. Thromb Haemost 1991;65:452.
17. Bentolila S, Horellou MH, Conard J, et al. Prevalence of anticardiolipin antibodies in patients with a history of deep venous thrombosis (DVT). Haemostasis 1994;24(suppl 1) 137.
18. Fijnheer R, de Valk B, Punt J, et al. Antiphospholipid antibodies in patients with thrombo-embolic disease: a prospective, controlled study. Br J Haematol 1994;87(suppl 1):180.
19. Stegnar M, Bozic B, Peternel P, et al. Prevalence of antiphospholipid antibodies in deep vein thrombosis. Thromb Haemost 1991;65:1005.
20. O'Donnel JR, Abbott WM, Athanasoulis CA, et al. The diagnosis of deep venous thrombosis in the outpatients by venography. Surg Gynecol Obstet 1980;150:69.
21. ++. Br J Haematol 1993;85:521.
22. Girolami A, Marafioti F, Rubertelli M, et al. Congenital heterozygous plasminogen deficiency associated with a severe thrombotic tendency. Acta Haematol 1986;75:54.
23. Girolami A, Marafioti F, Rubertelli M, et al. Antithrombin III Trento. A "new" congenital antithrombin III abnormality with a peculiar crossed-immunoelectrophoretic pattern in the absence of heparin. Acta Haematol 1984;72:71.
24. Exner T, Triplett DA, Tabener D, et al. Guidelines for testing and revised criteria for lupus anticoagulants. Thromb Haemost 1991;65:320.
25. Alving BM, Baldwin PE, Richards RL, et al. The dilute phospholipid aPTT: a sensitive assay for verification of lupus anticoagulant. Thromb Haemost 1985;54:709.
26. Triplett DA, Brandt JT, Kaczor D, et al. Laboratory diagnosis of lupus inhibitors: a comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure. Am J Clin Pathol 1983;79:678.
27. Triplett DA, Barna LK, Unger GA, et al. A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification. Thromb Haemost 1993;70:787.
28. Harris EN, Gharavi AE, Patel SP, et al. Evaluation of the anticardiolipin test in International Workshop 4 April 1986. Clin Exp Immunol 1987;68:215.
29. Bick RL. Disorders of hemostasis and thrombosis. Principles of clinical practice. New York: Thieme, 1985:288.
30. Bick RL, Jakway J, Baker W. Deep vein thrombosis: prevalence of etiologic factors and results of management in 100 consecutive patients. Semin Thromb Hemost 1992;18(2):267.
31. Long AA, Ginsberg J, Brill-Edwards P, et al. The relationship of antiphospholipid antibodies to thromboembolic disease in SLE: a cross-sectional study. Thromb Haemost 1991;66:520.
32. Simioni P, Zanon E, Prandoni P, et al. Lupus anticoagulant and antiphospholipid antibodies in outpatients with clinically suspected DVT. Lupus 1994;3:361.
33. Derksen RHWM, de Groot G, Kater L, et al. Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment. Ann Rheum Dis 1993;52:689.
34. Vianna JL, Khamashta MA, Ordi-Ros J, et al. Comparison of the primary and secondary antiphospholipid syndrome: a European Multicentre Study of 114 patients. Am J Med 1994;96:3.
35. Heijber H, Brandjes DPM, Buller HR, et al. Deficiencies of coagulation-inhibition and fibrinolytic proteins in outpatients with deep vein thrombosis. N Engl J Med 1990;323:1512.